BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9061051)

  • 1. Thromboxane A2 receptor mediation of calcium and calcium transients in rat cardiomyocytes.
    Dogan S; Turnbaugh D; Zhang M; Cofie DQ; Fugate RD; Kem DC
    Life Sci; 1997; 60(12):943-52. PubMed ID: 9061051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endothelin-1 production by a thromboxane A2 mimetic in rat heart smooth muscle cells.
    Chua CC; Hamdy RC; Chua BH
    Biochim Biophys Acta; 1996 Aug; 1313(1):1-5. PubMed ID: 8781542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons.
    Hsu KS; Huang CC; Kan WM; Gean PW
    Am J Physiol; 1996 Oct; 271(4 Pt 1):C1269-77. PubMed ID: 8897834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations by a thromboxane A2 analog (U46619) of calcium dynamics in isolated rat cardiomyocytes.
    Hoffmann P; Heinroth-Hoffmann I; Toraason M
    J Pharmacol Exp Ther; 1993 Jan; 264(1):336-44. PubMed ID: 8423535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL; Darius H; Lefer AM
    Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C; Korichneva I; Devynck MA
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
    J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
    Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
    Mistry M; Nasjletti A
    Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells.
    Coffman TM; Spurney RF; Mannon RB; Levenson R
    Am J Physiol; 1998 Aug; 275(2):F262-9. PubMed ID: 9691017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a rat kidney thromboxane A2 receptor: high affinity for the agonist ligand I-BOP.
    D'Angelo DD; Terasawa T; Carlisle SJ; Dorn GW; Lynch KR
    Prostaglandins; 1996 Oct; 52(4):303-16. PubMed ID: 8936585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets.
    BrĂ¼ne B; von Appen F; Ullrich V
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):993-9. PubMed ID: 7818507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thromboxane A2/endoperoxide antagonist SQ29548 on the contractile response to acetylcholine in newborn piglet cerebral arteries.
    Wagerle LC; Busija DW
    Circ Res; 1990 Mar; 66(3):824-31. PubMed ID: 2306808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.